Description

Stanozolol has been used with some success to treat venous insufficiency. It stimulates blood fibrinolysis and has been evaluated for the treatment of the more advanced skin changes in venous disease such as lipodermatosclerosis. Several randomized trials noted improvement in the area of lipodermatosclerosis, reduced skin thickness, and possibly faster ulcer healing rates with stanozolol.It is also being studied to treat hereditary angioedema, osteoporosis, and skeletal muscle injury.

Usual dose:

Men: 30-60 mg / everyday oral use Women: 20-40 mg / everyday oral use